The effect of electroporation pulses on functioning of the heart

Electrochemotherapy is an effective antitumor treatment currently applied to cutaneous and subcutaneous tumors. Electrochemotherapy of tumors located close to the heart could lead to adverse effects, especially if electroporation pulses were delivered within the vulnerable period of the heart or if they coincided with arrhythmias of some types. We examined the influence of electroporation pulses on functioning of the heart of human patients by analyzing the electrocardiogram. We found no pathological morphological changes in the electrocardiogram; however, we demonstrated a transient RR interval decrease after application of electroporation pulses. Although no adverse effects due to electroporation have been reported so far, the probability for complications could increase in treatment of internal tumors, in tumor ablation by irreversible electroporation, and when using pulses of longer durations. We evaluated the performance of our algorithm for synchronization of electroporation pulse delivery with electrocardiogram. The application of this algorithm in clinical electroporation would increase the level of safety for the patient and suitability of electroporation for use in anatomical locations presently not accessible to existing electroporation devices and electrodes.

[1]  M E Anderson,et al.  QT interval prolongation and arrhythmia: an unbreakable connection? , 2006, Journal of internal medicine.

[2]  Carl J. Wiggers,et al.  VENTRICULAR FIBRILLATION DUE TO SINGLE, LOCALIZED INDUCTION AND CONDENSER SHOCKS APPLIED DURING THE VULNERABLE PHASE OF VENTRICULAR SYSTOLE , 1940 .

[3]  Rollin McCraty,et al.  Analysis of twenty-four hour heart rate variability in patients with panic disorder , 2001, Biological Psychology.

[4]  L. Mir,et al.  Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Mojca Pavlin,et al.  Effect of cell electroporation on the conductivity of a cell suspension. , 2005, Biophysical journal.

[6]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[7]  Damijan Miklavčič,et al.  Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy , 2006 .

[8]  G. Bashein.  Electricity, Safety, and the Patient , 1990 .

[9]  Damijan Miklavcic,et al.  Real time electroporation control for accurate and safe in vivo non-viral gene therapy. , 2007, Bioelectrochemistry.

[10]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[11]  R. Sivaramakrishna.  Foreword: Imaging Techniques Alternative to Mammography for Early Detection of Breast Cancer , 2005 .

[12]  Tomaz Slivnik,et al.  Sequential finite element model of tissue electropermeabilization , 2005, IEEE Transactions on Biomedical Engineering.

[13]  M. Bureau,et al.  Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. , 2000, Biochimica et biophysica acta.

[14]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[15]  Julian F Thayer,et al.  Attentional and physiological characteristics of patients with dental anxiety. , 2003, Journal of anxiety disorders.

[16]  B. Rubinsky,et al.  Tissue Ablation with Irreversible Electroporation , 2005, Annals of Biomedical Engineering.

[17]  L. Mir,et al.  A Study of the Immunological Response to Tumor Ablation with Irreversible Electroporation , 2007, Technology in cancer research & treatment.

[18]  Gregor Sersa,et al.  The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses , 2006 .

[19]  Damijan Miklavčič,et al.  Electroporator with automatic change of electric field direction improves gene electrotransfer in-vitro , 2007, Biomedical engineering online.

[20]  R Balon,et al.  Decreased R‐R variance in panic disorder patients , 1990, Acta psychiatrica Scandinavica.

[21]  T. Jarm,et al.  An algorithm for synchronization of in vivo electroporation with ECG , 2005, Journal of medical engineering & technology.

[22]  A. Taddei,et al.  Long-term ST database: A reference for the development and evaluation of automated ischaemia detectors and for the study of the dynamics of myocardial ischaemia , 2003, Medical and Biological Engineering and Computing.

[23]  I R Efimov,et al.  The role of electroporation in defibrillation. , 2000, Circulation research.

[24]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[25]  L A Geddes,et al.  Strength-duration curves for cardiac pacemaking and ventricular fibrillation. , 1977, Cardiovascular Research Center bulletin.

[26]  J. Patrick Reilly,et al.  Applied Bioelectricity: From Electrical Stimulation to Electropathology , 1998 .

[27]  Metin Akay,et al.  Wiley encyclopedia of biomedical engineering , 2006 .

[28]  S. Orlowski,et al.  Mechanisms of electrochemotherapy. , 1999, Advanced drug delivery reviews.

[29]  Richard Heller,et al.  Electrochemotherapy, electrogenetherapy, and transdermal drug delivery : electrically mediated delivery of molecules to cells , 2000 .

[30]  Richard Heller,et al.  In vivo electroporation for gene therapy. , 2006, Human gene therapy.

[31]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[32]  G. A. Hofmann,et al.  Instrumentation and electrodes for in vivo electroporation. , 2000, Methods in molecular medicine.

[33]  J. Lehr,et al.  Finite element models of thoracic conductive anatomy: sensitivity to changes in inhomogeneity and anisotropy , 1994, IEEE Transactions on Biomedical Engineering.

[34]  M. Jaroszeski,et al.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. , 1999, Cancer research.

[35]  M J Ackerman,et al.  The Visible Human Project , 1998, Proc. IEEE.

[36]  Gregor Serša,et al.  Electrochemotherapy with Bleomycin in the Treatment of Hypernephroma Metastasis: Case Report and Literature Review , 2000, Tumori.

[37]  J F Thayer,et al.  Autonomic balance revisited: panic anxiety and heart rate variability. , 1998, Journal of psychosomatic research.

[38]  D Miklavcic,et al.  Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. , 2007, Neoplasma.

[39]  Damijan Miklavcic,et al.  Feasibility of Employing Model-Based Optimization of Pulse Amplitude and Electrode Distance for Effective Tumor Electropermeabilization , 2007, IEEE Transactions on Biomedical Engineering.

[40]  G. Ayers,et al.  Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. , 1994, Circulation.

[41]  D. Miklavčič,et al.  ELECTRIC PROPERTIES OF TISSUES , 2006 .

[42]  Boris Rubinsky,et al.  Irreversible Electroporation: Implications for Prostate Ablation , 2007, Technology in cancer research & treatment.

[43]  Mark R. Prausnitz,et al.  The effects of electric current applied to skin: A review for transdermal drug delivery , 1996 .

[44]  A. Ruha,et al.  A real-time microprocessor QRS detector system with a 1-ms timing accuracy for the measurement of ambulatory HRV , 1997, IEEE Transactions on Biomedical Engineering.

[45]  Chia-Hung Lin,et al.  Classification enhancible grey relational analysis for cardiac arrhythmias discrimination , 2006, Medical and Biological Engineering and Computing.

[46]  Deryck Duncalf,et al.  Electricity, Safety and the Patient , 1989 .

[47]  D.S. Benitez,et al.  A new QRS detection algorithm based on the Hilbert transform , 2000, Computers in Cardiology 2000. Vol.27 (Cat. 00CH37163).

[48]  Boris Rubinsky,et al.  Cancer Cells Ablation with Irreversible Electroporation , 2005, Technology in cancer research & treatment.

[49]  Damijan Miklavcic,et al.  The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals , 2005, IEEE Transactions on Biomedical Engineering.

[50]  L. Lehr,et al.  A three-dimensional finite element model of human transthoracic defibrillation: paddle placement and size , 1995, IEEE Transactions on Biomedical Engineering.

[51]  A. Houghton,et al.  MAKING SENSE OF THE ECG A HANDS-ON GUIDE , 2008 .

[52]  Steve W. Smye,et al.  Membrane electroporation theories: a review , 2006, Medical and Biological Engineering and Computing.

[53]  M R Franz,et al.  The vulnerable period for low and high energy T-wave shocks: role of dispersion of repolarisation and effect of d-sotalol. , 1996, Cardiovascular research.

[54]  Kleber de Magalhães Galvão,et al.  ELECTRIC STIMULATION OF ISOLATED HEARTS: AGE DEPENDENCE OF THE THRESHOLD ELECTRIC FIELD , 2001 .

[55]  U. Rajendra Acharya,et al.  Heart rate variability: a review , 2006, Medical and Biological Engineering and Computing.

[56]  David Cuesta-Frau,et al.  Unsupervised classification of ventricular extrasystoles using bounded clustering algorithms and morphology matching , 2007, Medical & Biological Engineering & Computing.

[57]  E. Neumann,et al.  Electroporation and Electrofusion in Cell Biology , 1989, Springer US.

[58]  Boris Rubinsky,et al.  A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. , 2007, The heart surgery forum.

[59]  Damijan Miklavčič,et al.  Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .